menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

Novo’s main Ozempic plant cited for quality lapses by FDA

2 1
30.10.2024
Novo has been racing to boost supplies of its drugs for obesity and diabetes after initially underestimating demand.

© Fortune